IQVIA Holdings | IQV - PE Price to Earnings


IQVIA Holdings reported 19.37 in PE Price to Earnings for its fiscal quarter ending in March of 2026.





Pe Change Date
Accenture 15.28 3.18 Dec/2025
Agilent 20.53 4.51 Mar/2026
Bruker 36.79 44.56 Mar/2026
Cardinal Health 30.4 5.87 Mar/2026
Celltrion 67.83 17.74 Dec/2025
Charles River Laboratories 29.26 14.31 Mar/2026
Cigna 10.56 0.76 Dec/2025
Cognizant Technology Solutions 11.35 4.14 Mar/2026
Cspc Pharmaceutical 24.4 1.13 Dec/2025
CVS Health 9.65 4.74 Mar/2026
Danaher 29.29 10.39 Mar/2026
Dentsply International 20.31 9.68 Mar/2026
Deva Holding AS 6.55 2.01 Sep/2023
Dianthus Therapeutics 3.8 1.53 Sep/2024
Divis Laboratories Ltd 59.75 6.76 Mar/2026
Elevance Health 12.4 0.98 Mar/2026
Humana 11.07 14.98 Mar/2026
IBM 24.1 5.96 Mar/2026
Illumina 32.45 2.07 Mar/2026
Infosys 24.15 2.67 Dec/2025
Kangmei Pharma 1.11K 2.04K Mar/2026
Knight Therapeutics 257.34 166.24 Dec/2025
Laboratorios Farma 18.78 6.64 Dec/2023
Laboratory Of America 25.51 4.65 Mar/2026
Malin Corporation 11.81 0.72 Jun/2023
McKesson 23.85 0.07 Dec/2025
Mettler Toledo International 27.34 5.07 Mar/2026
Organigram Holdings 235 224.49 Sep/2025
Ovoca Bio 1.83 3.29 Jun/2024
Pharma Mar 19.13 1.72 Mar/2026
Publicis 12.84 0.17 Dec/2025
Qiagen NV 20.54 0.1 Dec/2025
Quest Diagnostics 22.4 2.63 Mar/2026
Revvity 30.79 19.08 Mar/2026
Sartorius 43.44 84.64 Mar/2026
Sino Biopharmaceutical 17.03 0.89 Jun/2025
Thermo Fisher Scientific 27.71 3.29 Mar/2026
Tilray 11.56 80.19 Sep/2025
UnitedHealth 15.29 4.5 Mar/2026
Veeva Systems 26.77 9.47 Mar/2026
Veradigm 11.15 4.63 Sep/2022
Waters 29.75 5.54 Mar/2026
Zealand Pharma A/S 5.13 0.16 Dec/2025
Zz Pientze Pharmaceu 47.68 1.35 Mar/2026